• SPX
  • $5,954.55
  • 0.63 %
  • $37.44
  • DJI
  • $43,870.34
  • 1.06 %
  • $461.86
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,992.48
  • 0.14 %
  • $26.34
Aziyo Biologics, Inc. (AZYO) Stock Price, News & Analysis

Aziyo Biologics, Inc. (AZYO) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$1.4
Day's range
$1.54
50-day range
$1.1
Day's range
$2.42
  • Country: US
  • ISIN: US05479K1060
52 wk range
$1.1
Day's range
$9.01
  • CEO: Dr. C. Randal Mills Ph.D.
  • Website: Visit Site
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -5.39
  • Piotroski Score 3.00
  • Grade Overweight
  • Symbol (AZYO)
  • Company Aziyo Biologics, Inc.
  • Price $1.49
  • Changes Percentage (2.05%)
  • Change $0.03
  • Day Low $1.40
  • Day High $1.54
  • Year High $9.01

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/12/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $10.25
  • High Stock Price Target $10.50
  • Low Stock Price Target $10.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$2.18
  • Trailing P/E Ratio -0.68348623853211
  • Forward P/E Ratio -0.68348623853211
  • P/E Growth -0.68348623853211
  • Net Income $-32,897,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Aziyo Biologics, Inc. Frequently Asked Questions

  • What is the Aziyo Biologics, Inc. stock price today?

    Today's price of Aziyo Biologics, Inc. is $1.49 — it has increased by +2.05% in the past 24 hours. Watch Aziyo Biologics, Inc. stock price performance more closely on the chart.

  • Does Aziyo Biologics, Inc. release reports?

    Yes, you can track Aziyo Biologics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Aziyo Biologics, Inc. stock forecast?

    Watch the Aziyo Biologics, Inc. chart and read a more detailed Aziyo Biologics, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Aziyo Biologics, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Aziyo Biologics, Inc. stock ticker.

  • How to buy Aziyo Biologics, Inc. stocks?

    Like other stocks, AZYO shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Aziyo Biologics, Inc.'s EBITDA?

    Aziyo Biologics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Aziyo Biologics, Inc.’s financial statements.

  • What is the Aziyo Biologics, Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is -0.6688149308, which equates to approximately -66.88%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Aziyo Biologics, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Aziyo Biologics, Inc.'s financials relevant news, and technical analysis. Aziyo Biologics, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Aziyo Biologics, Inc. stock currently indicates a “sell” signal. For more insights, review Aziyo Biologics, Inc.’s technical analysis.

  • A revenue figure for Aziyo Biologics, Inc. for its last quarter?

    Aziyo Biologics, Inc. published it's last quarterly revenues at $6.13 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.